PARC is an EU-wide research and innovation partnership programme to support EU and national chemical risk assessment and risk management bodies with new data, knowledge, methods, networks and skills to address current, emerging and novel chemical safety challenges. PARC will facilitate the transition to next generation risk assessment to better protect human health and the environment, in line with the Green Deal?s zero-pollution ambition for a toxic free environment and will be an enabler for the future EU ?Chemicals Strategy for Sustainability?. It builds in part on the work undertaken and experience acquired in past and on-going research and innovation actions, but goes beyond by its vocation to establish an EU-wide risk assessment hub of excellence. To contribute to several expected impacts of destination 2 ?Living and working in a health-promoting environment?, PARC will organise the activities to reach three specific objectives: - An EU-wide sustainable cross-disciplinary network to identify and agree on research and innovation needs and to support research uptake into regulatory chemical risk assessment. - Joint EU research and innovation activities responding to identified priorities in support of current regulatory risk assessment processes for chemical substances and to emerging challenges. - Strengthening existing capacities and building new transdisciplinary platforms to support chemical risk assessment. The Partnership brings together Ministries and national public health and risk assessment agencies, as well as research organisations and academia from almost all of EU Member States. Representatives of Directorates-General of the EC and EU agencies involved in the monitoring of chemicals and the assessment of risks are also participating. PARC will meet the needs of risk assessment agencies to better anticipate emerging risks and respond to the challenges and priorities of the new European policies.

EQUAL-LIFE will develop and test combined exposure data using a novel approach to multi-modal exposures and their impact on children’s mental health and development. A combination of birth-cohort data with new sources of data, will provide insight into aspects of physical and social exposures hitherto untapped. It will do this at different scale levels and timeframes, while accounting for the distribution of exposures in social groups based on gender, ethnicity, social vulnerability. Beginning with child development and mental health, a set of theory-based questions is formulated, a wide range of relevant environmental and social hazards is defined and validated at the stakeholders end. Exposure assessment combines traditional GIS-based approaches with omics approaches and new sources of data that could explain aspects of the urban environment at a higher spatial and temporal granularity, and provide insight into untapped parameters relating to exposure (spatial quality of neighborhoods). These together form the early-life exposome. Statistical tools integrate data at different scale levels and times and combine e.g. machine learning, causal models with subgroups measures. EQUAL-LIFE uses data from birth-cohorts, longitudinal school data sets and cross-sectional studies (N=>250.000), including data on exposures, biomarkers, mental health and developmental outcomes, in their social context. EQUAL-LIFE contributes to the development/utilization of the exposome concept by 1) integrating the internal, external and social exposome 2) by studying a distinct set of effects on a child’s development and mental health 3) by characterizing/measuring/modelling the child’s environment at different stages and activity spaces 4) by looking at supportive environments for child development, rather than merely pollutants 5) by combining physical, social indicators with novel biomarkers and using new data sources describing child activity patterns and environments. EQUAL-LIFE is part of the European Human Exposome Network comprised of nine projects selected from this same call.

X-eHealth’s project stands herein for a project of strategic relevance for tomorrow’s European eHealth Union. Assembling at the time of this proposal submission a shared commitment of 47 health actors, the underlying idea of this project is to develop the basis for a workable, interoperable, secure and cross border Electronic Health Record exchange Format in order to lay the foundation for the advance of eHealth sector while using the 3 pillars put forward by the EC as reference. Aimed at promoting a faster and sustainable EU digital transformation, this Cooperative and Support Action is made up of 8 Work Package in which 4 exclusively focus on technical-functional activities (WP4 to WP7). From Generic Aspects to System Architecture and Integration, passing by Functional and Technical Specifications, X-eHealth objective is to move towards a uniform interoperable data-sharing format framework. In addition, to enhance EU’s public health state of play, WP1 and WP8 are responsible for implementation studies, practicality and continuity of eHealth interoperability development. On this basis and building upon the already in place Patient Summary, X-eHealth purpose is to develop the foundations for a common framework for medical imaging, discharge letters, laboratory results and rare diseases to flow both alongside citizens care pathway and across health entities between EU Member States and Neighbour Countries. Focus on cross-border services, this consortium aims to advance an interoperable Common European Health Data Space for citizens and health providers engagement in accordance with privacy and cybersecurity regulations. To achieve this end, X-eHealth gathers 36 consortium partners plus 5 collaborative partners and 6 eHealth skilled experts, eager to develop the abovementioned 4 domains, and distinguished by policy and political actors mixed with national competent authorities to indeed concretely plan, implement and maintain national eHealth infrastructures.